You might say that Express Scripts has a bad case of the blues lately. Its stock plummeted in the weeks following a public statement by Anthem, the largest Blue Cross and Blue Shield plan, that it ...
Cigna and Express Scripts completed their $67 billion combination in December, forming a healthcare giant with $140 billion in revenue. Express Scripts Chief Technology Officer Phil Finucane is one of ...
One week from now, national pharmacy benefit manager Express Scripts is expected to terminate its coverage with locally-owned Martella's Pharmacy. Our Emily Marines took a deeper dive into PBMs to ...
Two dozen Democrat and Republican lawmakers have raised issues about Express Scripts, the company that oversees the U.S. military's pharmacy program, charging that the benefits manager engages in ...
Cigna Group’s Express Scripts announced plans to offer a “cost-plus” drug pricing model for its clients next year amid growing scrutiny of pharmacy benefit managers. Employers, health plans and ...
They're the two biggest pharmacy benefits managers in the world, and they compete against each other every day. While CVS Health boasts a higher market cap thanks to its retail pharmacies, Express ...
On Tuesday, October 27, Express Scripts will announce its third-quarter results after the market closes. While shares have pulled back about 7% since it last reported results, the healthcare ...
The Kroger Co. expects to take a fourth-quarter sales hit due to a contract dispute with pharmacy benefit manager (PBM) Express Scripts Inc. Kroger Health, the health care services arm of ...
Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...
Express Scripts ClearNetworkSM offers employers and health plans a new option for simple, "cost-plus" pharmacy pricing for brand, generic, and specialty medications. "We are constantly innovating to ...
(Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover ...